Recombinant human granulocyte colony-stimulating foe injection

  • Favorite
Sinobioway Group Co., Ltd.

Business Type:Manufacturer

Country/Region:China

Ddu Verified

HOT Rank

6/10

Product Information

  • Indication:1. Cancer chemotherapy and other reasons lead to neutropenia. 2. To promote the increase in the number of neutrophils af
  • Specification:75g/0.3ml/branch, 100g/0.4ml/branch, 125g/0.5ml/branch, 150g/0.6ml/branch, 200g/0.8ml/branch, 300g/1.2ml/branch
  • Dosage Form:Injection
  • Active Ingredients:recombinant human granulocyte colony-stimulating factor
  • Route of Administration:Subcutaneous Injection
  • Shelf Life:3 years
  • Storage:2℃-8℃
  • Package:10 branch/box
  • Place of Origin:China
  • Qualification:Chinese GMP

Description

[Drug name]

Generic name: Recombinant Human Granulocyte Colony-stimulating Factor Injection

Product Name: Swiss blood NEW

[Indications]

1 cancer chemotherapy and other reasons lead to neutropenia.

2 to promote the increase in the number of neutrophils after bone marrow transplantation.

3 neutropenia in patients with bone marrow dysplasia syndrome;

4 neutropenia caused by aplastic anemia;

5 congenital, idiopathic neutropenia; bone marrow hyperplasia syndrome associated with neutropenia; periodic neutropenia.

[Taboo]

Allergy to this product or similar preparation and other preparations for the expression of E. coli.

[Adverse reactions]

Patients using this product after the main adverse reactions for bone and (or) muscle soreness and fatigue, individual patient visible rash, fever, runny nose or shivering cold symptoms, the adverse reactions were mild, easy to tolerate, generally do not need special treatment, after discontinuation of the drug is removed.

[Note] 

1 this product should be in the end of 24 to 48 hours after the end of chemotherapy drugs to use.

2 in the process of using this product should be regularly monitored weekly blood 2 times, especially the changes in the number of neutrophils.

3 the malignant proliferation of the myeloid cell system (acute myeloid leukemia, etc.) should be carefully used in this article.

4 long term use of the safety and effectiveness of the product has not been established, there have been reports of the spleen increased.

Although the clinical trial of this product without the occurrence of cases of allergic reaction, but similar foreign preparation had occurred a few allergic reactions (occurring rate < 1 / 4000), performance as rash, urticaria, facial edema, dyspnea, tachycardia tachycardia and hypotension, in the use of this product for 30 minutes in should be discontinued immediately, antihistamines, corticosteroids, bronchus spasmolysis agent and (or) epinephrine treatment after symptoms can disappear quickly. These cases should not be used again.

5 this product is only used under the guidance of doctors.




You Might Also Like
Change a group
Inquiry Cart(0)